Lexicon pharmaceuticals, inc./de (LXRX)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-66,611

-51,138

226,086

-23,018

-21,797

-16,783

-27,396

-34,549

-41,820

-22,321

-30,722

-35,059

-34,891

-22,435

-36,015

-38,112

-34,883

86,750

-35,282

-28,074

-28,076

-2,933

-40,498

-26,028

-30,835

-17,414

-31,658

-29,080

-25,974

-24,873

-29,539

-25,931

-29,868

-33,845

-26,103

-26,638

-29,629

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

906

935

908

910

901

912

918

928

925

924

923

918

634

508

511

516

521

66

60

246

355

204

526

554

644

669

576

825

793

916

1,055

1,094

1,125

1,135

1,181

1,264

1,307

Impairment of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

200

13,102

0

242

-

-

0

0

-

-

-

-

-2

-79

16

769

Increase in fair value of Symphony Icon, Inc. purchase liability

-

-

-

-

-

-

-

-

-

0

0

0

2,101

0

-2,146

478

965

782

3,404

-12

1,753

910

-1,072

448

1,142

-5,289

1,338

477

1,264

-200

5,844

2,162

2,081

1,568

2,336

1,804

1,058

Stock-based compensation

4,432

3,479

3,562

3,766

3,411

2,847

2,877

2,898

3,074

2,258

2,580

2,403

2,231

1,730

1,930

1,957

1,835

1,430

1,672

1,788

1,953

1,497

1,494

1,840

2,250

1,693

1,750

1,869

2,109

1,590

1,592

1,595

1,718

1,353

1,432

1,450

1,472

Amortization of debt issuance costs

362

378

379

362

346

379

365

285

307

187

158

144

110

138

139

125

125

140

139

179

62

63

12

25

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax benefit

-

-

-

-

-

-

-

-

-

-4,048

0

0

-8,652

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-24

0

12

-

12

-65

6

-

-78

-469

-264

-

-

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable

-26,397

-309

51,261

1,190

-1,534

3,011

-1,493

-76

-343

-3,271

5,583

-3,719

1,241

4,253

-280

277

-170

839

-244

146

-865

168

-116

-190

-319

-105

-119

151

-515

1,145

51

-4

-164

-139

-16

-326

87

(Increase) decrease in inventory

-96

-233

199

-329

-74

-75

2,613

30

164

-201

1,338

575

236

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Increase) decrease in prepaid expenses and other current assets

2,875

-653

-652

1,939

2,018

-727

-558

-331

-150

-23

-5,716

-202

6,498

1,435

-8,760

5,200

-4,134

816

-3,802

-3,957

1,570

1,173

1,405

-772

-1,934

2,621

-573

1,754

-2,089

2,655

-2,422

-1,439

-1,395

589

-463

-426

-565

Decrease in other assets

-102

-99

-144

-95

-91

-144

0

-3

3

-1

1

0

-33

7

25

0

0

53

-56

-20

-393

-26

0

15

11

-71

18

23

21

26

22

24

24

76

-28

51

315

Decrease in accounts payable and other liabilities

15,137

20,742

13,197

-5,671

-8,171

-15,007

1,938

-16,226

9,382

-137

10,531

2,434

-24,703

-5,121

24,523

-1,982

-3,836

-3,279

-6,250

2,024

1,302

5,321

-3,895

-4,568

1,876

3,565

-4,433

-3,156

905

-892

1,570

-534

851

-6,541

-1,464

1,489

-3,849

Decrease in deferred revenue

0

-61

-25,394

-544

9

2,589

-321

-6,239

-18,969

-14,110

-16,226

-6,413

-14,384

-17,920

-83,276

19,747

12,187

-172,199

475

93

278

-833

92

26

18

490

-62

5

5

293

0

0

0

45

-26

47

29

Net cash provided by (used in) operating activities

-22,054

-24,371

190,698

-26,900

-25,620

-27,128

-22,181

-52,523

-46,775

-33,711

-33,962

-32,225

-85,496

-48,791

-35,219

-47,878

-43,740

265,924

-25,485

-32,178

-23,485

-4,458

-21,190

-19,655

-30,319

-21,741

-23,935

-21,132

-24,271

-20,432

-25,069

-21,957

-27,002

-22,491

-20,218

-23,689

-21,540

Cash flows from investing activities:
Purchases of property and equipment

0

0

0

0

70

37

3

15

40

4

61

71

92

148

16

13

54

246

184

463

17

34

7

11

28

215

268

399

839

113

50

95

234

209

182

308

507

Proceeds from disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

330

4

362

291

708

809

22

6

45

57

78

6

1

0

3

106

2,473

43

Purchases of investments

33,222

145,398

70,281

19,450

87,256

35,512

34,837

2,746

46,892

208,636

-752

-916

60,905

89,024

117,212

10,451

208,986

243,892

12,049

-473

70,978

201,302

0

0

20,651

30,536

0

0

80,954

81,474

0

0

151,776

25,467

18,499

30,231

33,895

Maturities of investments

76,000

36,000

39,000

12,000

79,600

94,300

91,235

50,128

53,995

72,874

86,356

55,941

103,452

145,631

151,125

72,000

75,400

120,000

90,000

0

0

30,258

20,222

526

60,438

70,500

20,502

10,780

110,843

74,780

11,686

26,949

22,435

43,705

49,314

54,568

29,041

Net cash (used in) provided by investing activities

42,778

-109,398

-31,281

-7,450

-7,726

58,751

56,395

47,367

7,063

-135,766

87,047

56,786

42,455

56,459

33,897

61,536

-133,640

-124,138

77,768

340

-70,991

-170,716

20,506

1,223

40,568

39,771

20,240

10,426

29,107

-6,729

11,642

26,855

-129,575

18,032

30,739

26,502

-5,318

Cash flows from financing activities:
Proceeds from issuance of common stock, net of fees

-

-

-

-

-

182

158

367

25

2,506

54

4,316

1,111

681

2,191

568

184

0

114

0

0

201,945

163

86

76

210

527

98

249

37,054

779

224

52

160,592

1

28

160

Repurchase of common stock

923

0

0

0

941

0

0

0

972

0

0

0

1,679

0

0

0

621

0

0

0

357

0

0

0

887

0

0

0

873

0

0

0

285

0

0

0

108

Repayment of debt borrowings, net of fees

321

322

320

322

321

321

13,043

588

581

566

552

626

536

521

507

497

491

480

467

456

456

442

429

419

420

407

394

386

387

375

362

353

353

345

329

2,631

284

Other financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

0

78

-17

27

0

-27

0

-

-

-

-

146

-10

0

-136

0

0

0

0

Net cash used in financing activities

-1,244

-322

-320

-322

-1,262

-139

-356

-221

-1,528

147,845

-498

3,690

-1,104

160

1,684

71

-928

-471

-353

-378

-830

285,665

-266

-360

-1,231

-112

22

-288

-1,011

36,825

407

-129

-722

160,247

-328

-2,603

-232

Net increase (decrease) in cash and cash equivalents

19,480

-134,091

159,097

-34,672

-34,608

31,484

33,858

-5,377

-41,240

-21,632

52,587

28,251

-44,145

7,828

362

13,729

-178,308

141,315

51,930

-32,216

-95,306

110,491

-950

-18,792

9,018

17,918

-3,673

-10,994

3,825

9,664

-13,020

4,769

-157,299

155,788

10,193

210

-27,090

Supplemental disclosure of cash flow information:
Cash paid for interest

3,658

5,968

3,633

5,912

3,698

5,995

3,744

5,952

774

2,598

316

2,624

332

2,644

360

2,668

378

2,684

402

2,772

412

406

459

449

447

460

475

482

480

493

506

513

516

522

540

801

584

Supplemental disclosure of noncash investing and financing activities:
Common stock issued in satisfaction of Symphony Icon base payment obligation

-

-

-

-

-

-

-

-

-

0

0

0

10,499

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain on investments

-

-

-

-

-

-

147

176

-172

-

151

50

-69

-273

-258

39

516

-277

-40

75

86

-65

-3

-5

8

-36

7

-11

19

2

41

37

-78

-13

-37

31

35